| View |
|
DR-XY16502
|
Ganciclovir (As Sodium)
|
Cymevene
|
500 mg
|
Sterile Powder For IV Infusion
|
Anticytomegalovirus
|
Valdephram
|
France
|
Initial (Variation)
|
24 January 2023
|
24 January 2028
|
| View |
|
DR-XY16541
|
Finasteride
|
Proscar
|
5 mg
|
Tablet
|
-
|
AIAC International Pharma, LLC
|
U.S.A.
|
-
|
25 March 2021
|
25 April 2026
|
| View |
|
DR-XY16542
|
Bss (Balanced Salt Solution) Sterile Intraocular Irrigating Solution
|
Sodium Chloride + Potassium Chloride + Calcium Chloride + Magnesium Chloride
|
0.6% + 0.075% + 0.048% + 0.030%
|
Intraocular Irrigating Solution
|
Adjuvant to Surgery
|
Alcon Research, Ltd.
|
U.S.A.
|
Renewal
|
09 June 2022
|
16 August 2027
|
| View |
|
DR-XY16558
|
Cotrimoxazole
|
None
|
960mg
|
Tablet
|
-
|
SwissPharma Research Laboratories Inc.
|
Philippines
|
-
|
05 May 2020
|
08 December 2024
|
| View |
DR-XY16562_PI_01.pdf
|
DR-XY16562
|
SALBUTAMOL (AS SULFATE)
|
VENTAR
|
2mg/5mL
|
Syrup
|
BRONCHODILATOR
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
17 April 2024
|
03 August 2029
|
| View |
|
DR-XY16590
|
Pyrantel (As Embonate)
|
Diamintic
|
250 mg/ 5 mL
|
Suspension (Orange Flavor)
|
-
|
Diamond Laboratories Inc.
|
Philippines
|
-
|
16 April 2021
|
04 April 2026
|
| View |
|
DR-XY16597-B
|
Cefalexin (As Monohydrate)
|
Selzef
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporins)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
10 May 2027
|
| View |
|
DR-XY16608
|
Cefalexin (as Monohydrate)
|
Cefax
|
500 mg
|
Capsule
|
Antibacterials (Cephalosporins)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 May 2022
|
12 July 2027
|
| View |
|
DR-XY16632
|
Diclofenac Sodium
|
Voren
|
10mg/g (1% w/w)
|
Gel
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
02 August 2024
|
13 October 2029
|
| View |
|
DR-XY16668
|
Naproxen
|
Naprosyn LLE
|
500mg
|
Tablet
|
-
|
Recipharm Leganés S.L.U.
|
Spain
|
Automatic Renewal
|
23 March 2021
|
20 March 2026
|
| View |
|
DR-XY16681
|
Pheniramine Maleate + Naphazoline Hydrochloride
|
Decocon A
|
3 mg/250 mcg per mL
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antihistamine/Decongestant
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
16 November 2023
|
13 February 2029
|
| View |
|
DR-XY16703
|
Terbutaline Sulfate
|
Pulmoxcel
|
2.5mg/mL
|
Nebulizing Solution
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
14 July 2020
|
13 January 2025
|
| View |
DR-XY16736_PI_01.pdf
|
DR-XY16736
|
Goserelin (As Acetate)
|
Zoladex
|
3.6 mg
|
Depot In Pre-Filled Syringe (SC Injection)
|
-
|
AstraZeneca UK Limited
|
United Kingdom
|
Automatic Renewal (Variation)
|
16 December 2022
|
16 December 2027
|
| View |
|
DR-XY16774
|
Alprazolam
|
Xanor
|
1 mg
|
Tablet
|
Anxiolytic
|
Pfizer Pharmaceuticals LLC
|
Puerto Rico
|
Automatic Renewal
|
16 April 2020
|
21 March 2025
|
| View |
|
DR-XY16782
|
Ascorbic Acid
|
Pediafortan-C
|
100 mg /mL
|
Syrup (Oral Drops) Orange Flavor
|
-
|
Medi-Rx, Inc.
|
Philippines
|
-
|
27 May 2021
|
28 May 2026
|
| View |
DR-XY1680_PI_01.pdf
|
DR-XY1680
|
Terbutaline Sulfate
|
Bricanyl
|
2.5 mg/mL (5 mg/2 mL)
|
Solution for Nebulizing
|
Polyethylene (PE) Plastic Ampoule in 2 mL (net content) x 5's wrapped in white aluminium pouch (Box of 20's)
|
AstraZeneca AB
|
Sweeden
|
Automatic Renewal
|
28 April 2021
|
23 April 2026
|
| View |
|
DR-XY16804
|
Terbutaline Sulfate
|
None
|
1.5 mg/5mL
|
Syrup
|
Selective beta-2-adrenoreceptor agonist
|
Swisspharma Research Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
27 April 2021
|
29 March 2026
|
| View |
|
DR-XY16805-B
|
Cefalexin (As Monohydrate)
|
Infexin
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 June 2022
|
27 July 2027
|
| View |
|
DR-XY16826
|
Lacidipine
|
Lacipil
|
2 mg
|
Film Coated Tablet
|
Selective Calcium Channel Blockers with Mainly Vascular Effects (Dihydropyridine derivatives)
|
Glaxo Wellcome S.A.
|
Spain
|
Automatic Renewal
|
21 July 2023
|
18 August 2028
|
| View |
|
DR-XY16827
|
Lacidipine
|
Lacipil
|
4 mg
|
Film Coated Tablet
|
Selective Calcium Channel Blockers with Mainly Vascular Effects (Dihydropyridine derivatives)
|
Glaxo Wellcome S.A.
|
Spain
|
Automatic Renewal
|
21 July 2023
|
18 August 2028
|